Document ID: chunk:federal_register_of_legislation:F2021C00070:clause:1_1:p2
Version: federal_register_of_legislation:F2021C00070
Segment Type: clause
Provision Reference: sch 1 cl 1 (pt 2/2)
Character Range: 34153–36755

Dict = Dictionary                               (prev…) = previously
disallowed = disallowed by Parliament           Pt = Part(s)
Div = Division(s)                               r = regulation(s)/rule(s)
ed = editorial change                           reloc = relocated
exp = expires/expired or ceases/ceased to have  renum = renumbered
effect                                          rep = repealed
F = Federal Register of Legislation             rs = repealed and substituted
gaz = gazette                                   s = section(s)/subsection(s)
LA = Legislation Act 2003                       Sch = Schedule(s)
LIA = Legislative Instruments Act 2003          Sdiv = Subdivision(s)
(md) = misdescribed amendment can be given      SLI = Select Legislative Instrument
effect                                          SR = Statutory Rules
(md not incorp) = misdescribed amendment        Sub‑Ch = Sub‑Chapter(s)
cannot be given effect                          SubPt = Subpart(s)
mod = modified/modification                     underlining = whole or part not
No. = Number(s)                                 commenced or to be commenced

Endnote 3—Legislation history

Name                                                                                                                                                     Registration               Commencement                                     Application, saving and transitional provisions
National Health (Commonwealth Price—Pharmaceutical Benefits Supplied By Public Hospitals) Determination 2017 (PB 25 of 2017)                             31 Mar 2017 (F2017L00372)  1 Apr 2017 (s 2(1) item 1)
National Health (Commonwealth Price—Pharmaceutical Benefits Supplied By Public Hospitals) Amendment (Budget Measure) Determination 2019 (PB 57 of 2019)  1 July 2019 (F2019L00940)  1 Oct 2019 (s 2(1) item 1)                       —
National Health (Pharmaceutical Benefits) Legislation Amendment (Commonwealth Price—Mark‑ups) Determination 2020                                         24 Dec 2020 (F2020L01713)  Sch 1 (items 12–14): 1 Jan 2021 (s 2(1) item 1)  —

Endnote 4—Amendment history

Provision affected          How affected
Part 1
s 2.....................    rep LA s 48D
s 2C....................    rep LA s 48C
s 2E....................    ad F2019L00940
s 3.....................    am F2019L00940
Part 3
s 9.....................    am F2019L00940; F2020L01713
s 11....................    rs F2019L00940
                            am F2020L01713
s 14....................    ad F2019L00940
                            rs F2020L01713